Corebridge Financial, Inc. · CRBG · FY2026 Q1 · Calendar Q2 2026
Corebridge’s Equitable deal advances as reported results miss estimates
The supplied call analysis points to a long-term growth case centered on the Equitable merger, fee-income expansion, and digital distribution initiatives. Against that, reported EPS and revenue were below estimates, while merger execution, synergy timing, and annuity cash flows remain important uncertainties.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about CRBG FY2026 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management said the Equitable merger remains on track and outlined expense synergies and expected post-2028 EPS accretion. The call also emphasized AI-enabled digital agents and client tools, a payroll-integration platform for group retirement, and a Nippon Life partnership aimed at Japan. Reported EPS and revenue were below estimates.
Guidance delta
Management maintained guidance, according to the supplied transcript analysis.
Key takeaways
- Reported EPS was $1.05 versus $1.07 estimated; reported revenue was $4.085 billion versus $5.056 billion estimated.
- Management said the Equitable merger is on track, with $500 million of expense synergies and double-digit EPS accretion expected after 2028.
- The company highlighted AI and digital distribution initiatives, group-retirement payroll integration, and its Nippon Life partnership.
- Management reported $1.7 billion of holding-company liquidity and $1.4 billion returned to shareholders in Q1, per the supplied call analysis.
Management priorities
- Advance and complete the Equitable merger, subject to required approvals.
- Deploy AI and digital tools, including digital agents and client-facing tools.
- Roll out payroll integration for group retirement plans and develop co-manufactured products with Nippon Life in Japan.
Follow CRBG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Nov 4, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 21, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 12, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 12, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 7, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 7, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 6, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 20, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Aug 11, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 10, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 12, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 14, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Mar 3, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jun 27, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | Jan 10, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 2, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 9, 2024 |
| Citigroup | Neutral | Neutral | Maintain | Aug 9, 2023 |
| Credit Suisse | Neutral | Outperform | Downgrade | Jan 13, 2023 |
Named analyst price targets
Upside is calculated against the persisted previous close $35.74. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Analyst unavailable | $40 | $35.17 | +11.9% | Oct 7, 2026 |
| UBS | Michael Ward | $36 | $34.84 | +0.7% | Oct 6, 2026 |
| Evercore ISI | Analyst unavailable | $44 | $32.57 | +23.1% | Aug 20, 2026 |
| Wells Fargo | Wes Carmichael | $39 | $33.12 | +9.1% | Aug 19, 2026 |
| Piper Sandler | Analyst unavailable | $38 | $33.39 | +6.3% | Aug 12, 2026 |
| Piper Sandler | Analyst unavailable | $36 | $30.68 | +0.7% | Jul 15, 2026 |
| Jefferies | Analyst unavailable | $45 | $30.3 | +25.9% | Jul 10, 2026 |
| Mizuho Securities | Yaron Kinar | $36 | $29.85 | +0.7% | Jul 9, 2026 |
| Piper Sandler | Analyst unavailable | $31 | $27.74 | -13.3% | May 26, 2026 |
| Wells Fargo | Analyst unavailable | $35 | $26.34 | -2.1% | May 12, 2026 |
| UBS | Analyst unavailable | $29 | $26.94 | -18.9% | Apr 28, 2026 |
| Mizuho Securities | Yaron Kinar | $31 | $24.6 | -13.3% | Apr 13, 2026 |
| Mizuho Securities | Analyst unavailable | $39 | $31.45 | +9.1% | Feb 11, 2026 |
| Barclays | Alex Scott | $34 | $31.19 | -4.9% | Feb 10, 2026 |
| Wells Fargo | Analyst unavailable | $37 | $30.51 | +3.5% | Jan 13, 2026 |
| UBS | Analyst unavailable | $33 | $30.65 | -7.7% | Jan 8, 2026 |
| Barclays | Alex Scott | $35 | $30.44 | -2.1% | Jan 8, 2026 |
| Mizuho Securities | Yaron Kinar | $38 | $32.16 | +6.3% | Dec 15, 2025 |
| Morgan Stanley | Analyst unavailable | $35 | $32.64 | -2.1% | Dec 15, 2025 |
| Morgan Stanley | Bob Huang | $33 | $29.12 | -7.7% | Nov 17, 2025 |
| Evercore ISI | Analyst unavailable | $37 | $30.54 | +3.5% | Nov 5, 2025 |
| Evercore ISI | Thomas Gallagher | $38 | $32.06 | +6.3% | Oct 9, 2025 |
| Barclays | Alex Scott | $39 | $32.42 | +9.1% | Oct 8, 2025 |
| Morgan Stanley | Analyst unavailable | $39 | $32.28 | +9.1% | Oct 7, 2025 |
| Piper Sandler | Analyst unavailable | $40 | $32.28 | +11.9% | Oct 7, 2025 |
| Barclays | Analyst unavailable | $46 | $33.68 | +28.7% | Sep 5, 2025 |
| UBS | Analyst unavailable | $28 | $31.9 | -21.7% | Apr 2, 2025 |
| UBS | Analyst unavailable | $43 | $34.68 | +20.3% | Feb 28, 2025 |
| Barclays | Alex Scott | $33 | $28.48 | -7.7% | Sep 4, 2024 |
| Evercore ISI | Thomas Gallagher | $34 | $33.84 | -4.9% | May 16, 2024 |
| Piper Sandler | John Barnidge | $35 | $29.37 | -2.1% | May 6, 2024 |
| RBC Capital | Mark Dwelle | $33 | $28.68 | -7.7% | May 6, 2024 |
| RBC Capital | Mark Dwelle | $32 | $28.1 | -10.5% | Apr 5, 2024 |
| Piper Sandler | John Barnidge | $34 | $28.1 | -4.9% | Apr 5, 2024 |
| Credit Suisse | Analyst unavailable | $23 | $21.1 | -35.6% | Jan 13, 2023 |
| Morgan Stanley | Analyst unavailable | $26 | $22.04 | -27.3% | Nov 17, 2022 |
| Morgan Stanley | Nigel Dally | $25 | $19.94 | -30.1% | Oct 10, 2022 |
| Goldman Sachs | Alex Scott | $23 | $19.69 | -35.6% | Oct 10, 2022 |
Track every rating change on CRBG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCorebridge Financial, Inc. is a prominent financial services company primarily operating within the United States, dedicated to offering a broad spectrum of retirement and insurance solutions. Its business operations are strategically organized across four key segments: Individual Retirement, Group Retirement, Life Insurance, and Institutional Markets. Within the Individual Retirement division, customers can access a variety of offerings, including fixed, fixed-indexed, and variable annuities, alongside retail mutual funds. The Group Retirement segment caters to employer-sponsored defined contribution plans and their participants, providing essential services such as record-keeping, plan administration, and compliance management.…
Historical context
All CRBG earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| APO Apollo Global Management, Inc. | FY2026 Q3 · Calendar Q4 2026 | -5.5% | -4.9% | Apollo Posts Record Q3 Earnings, Reaffirms 2027 Growth Targets |
| EQH Equitable Holdings, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +1.8% | EQH reports Q3 EPS growth and strong retirement inflows as merger work advances |
| PS Pershing Square Inc. | FY2026 Q3 · Calendar Q4 2026 | -1.5% | +0.1% | Pershing Square emphasizes insurance buildout and new fund plans |
| APOS Apollo Global Management, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -0.5% | Apollo posted record Q3 fee and spread earnings while funding a larger private-markets buildout |
| EQH-PA Equitable Holdings, Inc. | FY2026 Q3 · Calendar Q4 2026 | +14.5% | — | Equitable Holdings: EPS Growth, Corebridge Synergies in Focus |
Latest beats and misses
Who reports nextBeat on EPS
- PFEFY2026 Q3 · November 3, 2026+18.4% EPS-2.2% move
- DTFY2027 Q2 · November 3, 2026+10.0% EPS-14.7% move
- TEVAFY2026 Q3 · November 3, 2026+19.4% EPS+3.0% move
- DOCNFY2026 Q3 · November 3, 2026+41.8% EPS+0.8% move
- YUMFY2026 Q3 · November 3, 2026+3.3% EPS-0.4% move
- SHOPFY2026 Q3 · November 3, 2026+6.2% EPS-8.7% move
Missed on EPS
- TRIFY2026 Q3 · November 3, 2026-9.0% EPS-9.9% move
- APOFY2026 Q3 · November 3, 2026-5.5% EPS-4.9% move
- FMSFY2026 Q3 · November 3, 2026-1.7% EPS-3.9% move
- PSFY2026 Q3 · November 2, 2026-1.5% EPS+0.1% move
- DOCFY2026 Q3 · November 2, 2026-68.5% EPS+0.4% move
- CRBGFY2026 Q3 · November 2, 2026-0.8% EPS+2.5% move
Get the CRBG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-11-04T06:00:45.519924+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-04T06:00:45.517162+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-04. For educational purposes only; not investment advice.